Related Experiment Video
Updated: Jun 18, 2026
08:21
Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
Insider access: pepducin symposium explores a new approach to GPCR modulation
Jacquelyn Miller1, Anika Agarwal, Lakshmi A Devi
1MacDougall Biomedical Communications, Wellesley, Massachusetts, USA.
Annals of the New York Academy of Sciences
|November 21, 2009
Summary
Scientists explored G protein-coupled receptors (GPCRs), crucial drug targets, and a novel approach using pepducins. Pepducins are synthetic molecules that modulate GPCR activity from within the cell membrane for therapeutic potential.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- G protein-coupled receptors (GPCRs) are a critical superfamily of membrane receptors involved in numerous human signaling pathways.
- GPCRs represent significant molecular targets in contemporary drug discovery and pharmaceutical development.
- Despite decades of research, the complete understanding of GPCR function remains an active area of scientific inquiry.
Framework:
- The Pepducin Science Symposium convened international scientists to discuss GPCR research.
- The symposium highlighted the potential of modulating specific GPCR signaling pathways for treating diseases.
- Pepducins, a novel class of synthetic lipopeptides, were presented as a new strategy to target GPCRs.
Implementation:
- Pepducins function as pharmacophores designed to interact with GPCRs.
- These molecules modulate the activity of heptahelical GPCRs.
- The mechanism of action involves interaction from within the cell membrane.
Implications:
- Modulating GPCRs offers significant therapeutic potential for various pathological conditions.
- Pepducins represent a promising innovative approach in pharmaceutical development.
- Further research into pepducin-GPCR interactions could lead to novel drug therapies.
More Related Videos
Related Concept Videos
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
01:30Transducer Mechanism: G Protein–Coupled Receptors
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
GPCRs are also called heptahelical, 7TM, or...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...